Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.4K Hold
84
0.01% 244
2025
Q4
$14.8K Hold
84
0.01% 236
2025
Q3
$11.8K Hold
84
0.01% 237
2025
Q2
$10.6K Hold
84
0.01% 269
2025
Q1
$11.5K Sell
84
-84
-50% -$12K 0.01% 239
2024
Q4
$25.7K Sell
168
-1,006
-86% -$170K 0.01% 247
2024
Q3
$228K Hold
1,174
0.14% 114
2024
Q2
$272K Hold
1,174
0.17% 113
2024
Q1
$253K Hold
1,174
0.15% 116
2023
Q4
$304K Buy
+1,174
New +$288K 0.21% 97

Other funds holding BIIB

Hara Capital's BIIB Position: Q1 2026 in Review

Hara Capital held its Biogen (BIIB) position steady in Q1 2026 at 84 shares worth $15.4K. The position accounts for 0.01% of the portfolio, ranked #244.

Hara Capital first reported a position in BIIB in Q4 2023 and has held it in 10 quarters since. The position peaked at $304K in Q4 2023. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Hara Capital held 84 shares of Biogen worth $15.4K as of Q1 2026.
  • Hara Capital left its Biogen share count unchanged in Q1 2026.
  • Biogen made up 0.01% of Hara Capital's portfolio in Q1 2026, its #244 holding.
  • Hara Capital first reported a position in Biogen in Q4 2023 and has held it in 10 quarters since.
  • Hara Capital's Biogen position peaked at $304K in Q4 2023.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Hara Capital's 13F filing for Q1 2026, filed 14 May 2026.